Amarin Reports Preliminary 2015 Net Product Sales and Provides 2016 Revenue and Business Outlook Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports Preliminary 2015 Net Product Sales and Provides 2016 Revenue and Business Outlook
Amarin Reports First Quarter 2015 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports First Quarter 2015 Financial Results and Provides Update on Operations
Amarin to Present at the Jefferies 2015 Global Healthcare Conference Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Present at the Jefferies 2015 Global Healthcare Conference
Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa(R) (Icosapent Ethyl) Capsules Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa(R) (Icosapent Ethyl) Capsules
New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association Scientific Sessions in Boston Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association Scientific Sessions in Boston
New In Vitro Eicosapentaenoic Acid Study Data to Be Presented at the National Lipid Association Scientific Sessions in Chicago Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about New In Vitro Eicosapentaenoic Acid Study Data to Be Presented at the National Lipid Association Scientific Sessions in Chicago
Amarin to Report Second Quarter 2015 Results and Host Conference Call on August 6, 2015 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report Second Quarter 2015 Results and Host Conference Call on August 6, 2015
Amarin Announces Upcoming Presentations of Two Eicosapentaenoic Acid (EPA) Studies at the American Society for Preventive Cardiology (ASPC) Annual Cardiovascular Disease Prevention Conference and the Kern Lipid Conference Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Upcoming Presentations of Two Eicosapentaenoic Acid (EPA) Studies at the American Society for Preventive Cardiology (ASPC) Annual Cardiovascular Disease Prevention Conference and the Kern Lipid Conference
Amarin Reports Second Quarter 2015 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports Second Quarter 2015 Financial Results and Provides Update on Operations
First Amendment Decision a Win for Amarin and Physician Plaintiffs Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about First Amendment Decision a Win for Amarin and Physician Plaintiffs
